NRG Therapeutics is passionate about bringing new medicines and hope to the growing number of people worldwide living with debilitating neurodegenerative disorders.

An innovative, clinical stage neuroscience drug discovery company building a pipeline of disease-modifying drug candidates, NRG is focused on therapeutic approaches that will rectify mitochondrial function and slow or halt the progression of neurodegenerative diseases such as amyotrophic lateral sclerosis, ALS (also known as motor neuron disease, MND) and Parkinson’s.

The company benefits from the drug discovery and neuroscience expertise and insights, and biotech experience of its founders, leadership team, investors, advisors, and collaborators.